Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Individuals With Obesity or Overweight but Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Moiz, Areesha
Levett, Jeremy
Filion, Kristian B.
Peri, Katya
Reynier, Pauline
Eisenberg, Mark J.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Obesity; Pharmacology; Weight loss; Weight Management;
D O I：
10.1161/circ.148.suppl_1.15741
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15741
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Moiz, Areesha
    Levett, Jeremy Y.
    Filion, Kristian B.
    Peri, Katya
    Reynier, Pauline
    Eisenberg, Mark J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 222 : 121 - 130
  • [2] Efficacy and safety of once-weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus-A systematic review and meta-analysis of randomized controlled trials
    Kommu, Sharath
    Berg, Richard L.
    OBESITY REVIEWS, 2024, 25 (09)
  • [3] Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Shi, Fang-Hong
    Li, Hao
    Cui, Min
    Zhang, Zai-Li
    Gu, Zhi-Chun
    Liu, Xiao-Yan
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [4] Once-weekly semaglutide for obesity or overweight: A systematic review and meta-analysis
    He, Ke
    Guo, Qing
    Zhang, Haijuan
    Xi, Wang
    Li, Jingxin
    Jing, Zeng
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 722 - 726
  • [5] Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis
    Zhong, Ping
    Zeng, Hai
    Huang, Miaochun
    Fu, Wenbin
    Chen, Zhixia
    ENDOCRINE, 2022, 75 (03) : 718 - 724
  • [6] Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis
    Ping Zhong
    Hai Zeng
    Miaochun Huang
    Wenbin Fu
    Zhixia Chen
    Endocrine, 2022, 75 : 718 - 724
  • [7] Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
    Gao, Xueqin
    Hua, Xiaoli
    Wang, Xu
    Xu, Wanbin
    Zhang, Yu
    Shi, Chen
    Gu, Ming
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in Overweight or Obese Adults: A Systematic Review with Meta-Analysis
    Dorneles, Gilson
    Algeri, Ellen
    Lauterbach, Gerhard
    Pereira, Marcelo
    Fernandes, Brigida
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2024, 132 (06) : 316 - 327
  • [9] Efficacy and Safety of Semaglutide for Weight Loss in Obesity without Diabetes: A Systematic Review and Meta-Analysis
    Tan, Hanna Clementine
    Dampil, Oliver Allan
    Marquez, Maricar Mae
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2022,
  • [10] Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis
    Clementine Tan, Hanna
    Allan Dampil, Oliver
    Mae Marquez, Maricar
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2022, 37 (02): : 65 - 72
12345